CUE Stock Earnings: Cue Biopharma Beats EPS, Beats Revenue for Q1 2024 biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.
Cue Biopharma, Inc. (NASDAQ:CUE – Get Free Report) saw a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 4,780,000 shares, an increase of 13.8% from the March 31st total of 4,200,000 shares. Based on an average trading volume of 256,300 shares, the short-interest ratio […]
Cue Biopharma (NASDAQ:CUE – Get Free Report)‘s stock had its “outperform” rating restated by stock analysts at Oppenheimer in a note issued to investors on Tuesday, Benzinga reports. They currently have a $10.00 target price on the stock. Oppenheimer’s target price suggests a potential upside of 390.20% from the company’s current price. Several other research […]
Cue Biopharma (NASDAQ:CUE) Receives Overweight Rating from Piper Sandler theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.